Filing Details
- Accession Number:
- 0001586939-14-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-11 17:58:20
- Reporting Period:
- 2014-06-09
- Filing Date:
- 2014-06-11
- Accepted Time:
- 2014-06-11 17:58:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586939 | D Peter Flynn | C/O Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-09 | 1,260 | $1.63 | 6,645 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-09 | 1,955 | $7.00 | 4,690 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-10 | 699 | $1.63 | 5,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-10 | 1,350 | $7.00 | 4,039 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-09 | 1,260 | $0.00 | 1,260 | $1.63 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-10 | 699 | $0.00 | 699 | $1.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,556 | 2022-02-08 | No | 4 | M | Direct | |
| 28,857 | 2022-02-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2013.
- The shares subject to this option shall vest and become exercisable at the rate of 1/4th of the shares on May 30, 2012 and 1/48th of the shares each month thereafter such that this option is fully exercisable on May 30, 2015. This option is subject to accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.
- Not applicable.
Billionaire Hedge Funds
